CD4 and cancer: Furthermore, DEX administration has been shown to enhance host protective immunity, including increases in NK and CD4+ cells and CD4/CD8 and T helper cell (Th)1/Th2 ratios, via suppression of the HPA axis and SNS stimulation of the surgical stress response in the setting of cancer surgery (53).